Back

Synergistic effect of Interleukin-1beta and cholesterol efflux capacity on outcomes in acute myocardial infarction patients

26 August 2023 (14:10 - 14:20)
Organised by: Logo
Congress Presentation Part of: Markers of inflammation and outcomes in patients with acute coronary syndromes Inflammation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Mr Clement Materne

Paris (France)

4 More presentations in this session

Presentation thumbnail
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition with evolocumab decreases myocardial inflammation in individuals with acute coronary syndrome (ACS)
Doctor E. Ziogos (Baltimore, US)
Abstract Slides Video
Presentation thumbnail
Analysis of immune infiltration and cuproptosis-related genes in acute myocardial infarction
Doctor Y. Xiao (Changsha, CN)
Abstract Slides Video
Presentation thumbnail
Impact of nutritional status and systemic immune-inflammation index on mortality in patients with acute myocardial infarction
Doctor H. Kwak (Daegu, KR)
Abstract Slides Video
Presentation thumbnail
Inflammatory biomarkers and long-term outcome in young stable patients 3 months after a first myocardial infarction
Doctor S. Cederstrom (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Markers of inflammation and outcomes in patients with acute coronary syndromes
Video

The Event

Event poster

ESC Congress 2023

26 August 2023 14:10 CET
You may be interested in
thumbnail
Congress Session
Markers of inflammation and outcomes in patients with acute coronary syndromes
thumbnail
Congress Session
Novel biomarkers for cardiovascular risk assessment
thumbnail
Congress Presentation
Extinguishing the fire: tackling inflammation in PCI patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources